Aclaris Therapeutics ACRS Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's operating income?
- Aclaris Therapeutics (ACRS) reported operating income of -$22.19M in Q1 2026.
- How has Aclaris Therapeutics's operating income changed year-over-year?
- Aclaris Therapeutics's operating income decreased by 22.7% year-over-year, from -$18.08M to -$22.19M.
- What is the long-term trend for Aclaris Therapeutics's operating income?
- Over 4 years (2021 to 2025), Aclaris Therapeutics's operating income has grown at a -3.9% compound annual growth rate (CAGR), from -$89.72M to -$76.38M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.